Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors

Acetylcholinesterase (AChE) is one of the classical targets in the treatment of Alzheimer’s disease (AD). Inhibition of AChE slows down the hydrolysis of acetycholine and increases choline levels, improving the cognitive function. The achieved success of plant-based natural drugs acting as AChE inhi...

Full description

Bibliographic Details
Main Authors: Mariyana Atanasova, Ivan Dimitrov, Stefan Ivanov, Borislav Georgiev, Strahil Berkov, Dimitrina Zheleva-Dimitrova, Irini Doytchinova
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/10/3139
_version_ 1827667541973008384
author Mariyana Atanasova
Ivan Dimitrov
Stefan Ivanov
Borislav Georgiev
Strahil Berkov
Dimitrina Zheleva-Dimitrova
Irini Doytchinova
author_facet Mariyana Atanasova
Ivan Dimitrov
Stefan Ivanov
Borislav Georgiev
Strahil Berkov
Dimitrina Zheleva-Dimitrova
Irini Doytchinova
author_sort Mariyana Atanasova
collection DOAJ
description Acetylcholinesterase (AChE) is one of the classical targets in the treatment of Alzheimer’s disease (AD). Inhibition of AChE slows down the hydrolysis of acetycholine and increases choline levels, improving the cognitive function. The achieved success of plant-based natural drugs acting as AChE inhibitors, such as galantamine (GAL) from Galanthus genus and huperzine A from Huperzia serrate (approved drug in China), in the treatment of AD, and the fact that natural compounds (NCs) are considered as safer and less toxic compared to synthetic drugs, led us to screen the available NCs (almost 150,000) in the ZINC12 database for AChE inhibitory activity. The compounds were screened virtually by molecular docking, filtered for suitable ADME properties, and 32 ligands from 23 structural groups were selected. The stability of the complexes was estimated via 1 μs molecular dynamics simulation. Ten compounds formed stable complexes with the enzyme and had a vendor and a reasonable price per mg. They were tested for AChE inhibitory and antioxidant activity. Five compounds showed weak AChE inhibition and three of them exhibited high antioxidant activity.
first_indexed 2024-03-10T03:19:48Z
format Article
id doaj.art-0cf891b18ecc4d3cbe1f9fd6168533d7
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T03:19:48Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-0cf891b18ecc4d3cbe1f9fd6168533d72023-11-23T12:21:37ZengMDPI AGMolecules1420-30492022-05-012710313910.3390/molecules27103139Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase InhibitorsMariyana Atanasova0Ivan Dimitrov1Stefan Ivanov2Borislav Georgiev3Strahil Berkov4Dimitrina Zheleva-Dimitrova5Irini Doytchinova6Chemistry Department, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaChemistry Department, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaChemistry Department, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaInstitute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 1113 Sofia, BulgariaInstitute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 1113 Sofia, BulgariaChemistry Department, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaChemistry Department, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaAcetylcholinesterase (AChE) is one of the classical targets in the treatment of Alzheimer’s disease (AD). Inhibition of AChE slows down the hydrolysis of acetycholine and increases choline levels, improving the cognitive function. The achieved success of plant-based natural drugs acting as AChE inhibitors, such as galantamine (GAL) from Galanthus genus and huperzine A from Huperzia serrate (approved drug in China), in the treatment of AD, and the fact that natural compounds (NCs) are considered as safer and less toxic compared to synthetic drugs, led us to screen the available NCs (almost 150,000) in the ZINC12 database for AChE inhibitory activity. The compounds were screened virtually by molecular docking, filtered for suitable ADME properties, and 32 ligands from 23 structural groups were selected. The stability of the complexes was estimated via 1 μs molecular dynamics simulation. Ten compounds formed stable complexes with the enzyme and had a vendor and a reasonable price per mg. They were tested for AChE inhibitory and antioxidant activity. Five compounds showed weak AChE inhibition and three of them exhibited high antioxidant activity.https://www.mdpi.com/1420-3049/27/10/3139acetylcholinesterase (AChE)natural compoundsvirtual screeningmolecular dockingmolecular dynaminsAlzheimer’s disease (AD)
spellingShingle Mariyana Atanasova
Ivan Dimitrov
Stefan Ivanov
Borislav Georgiev
Strahil Berkov
Dimitrina Zheleva-Dimitrova
Irini Doytchinova
Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
Molecules
acetylcholinesterase (AChE)
natural compounds
virtual screening
molecular docking
molecular dynamins
Alzheimer’s disease (AD)
title Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
title_full Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
title_fullStr Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
title_full_unstemmed Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
title_short Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
title_sort virtual screening and hit selection of natural compounds as acetylcholinesterase inhibitors
topic acetylcholinesterase (AChE)
natural compounds
virtual screening
molecular docking
molecular dynamins
Alzheimer’s disease (AD)
url https://www.mdpi.com/1420-3049/27/10/3139
work_keys_str_mv AT mariyanaatanasova virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT ivandimitrov virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT stefanivanov virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT borislavgeorgiev virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT strahilberkov virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT dimitrinazhelevadimitrova virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors
AT irinidoytchinova virtualscreeningandhitselectionofnaturalcompoundsasacetylcholinesteraseinhibitors